Risk factors for various causes of failure in initial corneal grafts

Archives of Ophthalmology

Volumn 121, Issue 8, 2003, Pages 1087-1092

  Price, Marianne O ^a   Thompson Jr , Robert W ^b   Price Jr , Francis W ^c  

^a Lautert)   (United States)

^b Kansas City Eye Clinic   (United States)

^c Corneal Consultants of Indiana ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGLAUCOMA AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CORNEA TRANSPLANTATION; DIABETES MELLITUS; DRUG EFFECT; FEMALE; GRAFT FAILURE; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; KAPLAN MEIER METHOD; KERATOPLASTY; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RACE; REGRESSION ANALYSIS; RISK FACTOR; VASCULARIZATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; CORNEA; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; INFANT; KERATOPLASTY, PENETRATING; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 0042563088     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.121.8.1087     Document Type: Article

References (35)

1. Ing JJ, Ing HH, Nelson LR, et al. Ten-year postoperative results of penetrating keratoplasty. Ophthalmology. 1998;105:1855-1865.
2. Inoue K, Amano S, Oshika T, et al. A 10-year review of penetrating keratoplasty. Jpn J Ophthalmol. 2000;44:139-145.
3. Williams KA, Muehlberg SM, Bartlett CM, et al. The Australian Corneal Graft Registry: 1999 Report. Adelaide, Australia: Snap Printing; 2000.
4. Frequently asked questions. Eye Bank Association of America Web site. Available at: http://www.restoresight.org/general/faqs.htm#12. Accessibility verified March 2003.
5. Price FW Jr, Whitson WE, Johns S, et al. Risk factors for corneal graft failure. J Refract Surg. 1996;12:134-147.
6. Sit M, Weisbrod DJ, Naor J, et al. Corneal graft outcome study. Cornea. 2001; 20:129-133.
7. Vail A, Gore SM, Bradley BA, Easty DL, Rogers CA, for the Corneal Transplant Follow-up Study Collaborators. Corneal graft survival and visual outcome: a multicenter study. Ophthalmology. 1994;101:120-127.
8. Dandona L, Naduvilath TJ, Janarthanan M, et al. Survival analysis and visual outcome in a large series of corneal transplants in India. Br J Ophthalmol. 1997; 81:726-731.
9. Price FW Jr, Whitson WE, Collins KS, et al. Five-year corneal graft survival: a large, single-center patient cohort. Arch Ophthalmol. 1993;111:799-805.
10. Dandona L, Naduvilath TJ, Janarthanan M, et al. Causes of corneal graft failure in India. Indian J Ophthalmol. 1998;46:149-152.
11. Price FW Jr, Whitson WE, Marks RG. Graft survival in four common groups of patients undergoing penetrating keratoplasty. Ophthalmology. 1991;98:322-328.
12. Thompson RW Jr, Price MO, Bowers PJ, et al. Long-term graft survival following penetrating keratoplasty. Ophthalmology. In press.
13. Maguire MG, Stark WJ, Gottsch JD, et al, for the Collaborative Corneal Transplantation Studies Research Group. Risk factors for corneal graft failure and rejection in the collaborative corneal transplantation studies. Ophthalmology. 1994; 101:1536-1547.
14. Boisjoly HM, Tourigny R, Bazin R, et al. Risk factors of corneal graft failure. Ophthalmology. 1993;100:1728-1735.
15. Chipman ML, Slomovic AS, Rootman D, et al. Changing risk for early transplant failure. Can J Ophthalmol. 1993;28:254-258.
16. Wilson SE, Kaufman HE. Graft failure after penetrating keratoplasty. Surv Ophthalmol. 1990;34:325-356.
17. Sherwood MB, Grierson I, Millar L, et al. Long-term morphologic effects of antiglaucoma drugs on the conjunctiva and Tenon's capsule in glaucomatous patients. Ophthalmology. 1989;96:327-335.
18. Baudouin C, Pisella PJ, Fillacier K, et al. Ocular surface inflammatory changes induced by topical antiglaucoma drugs. Ophthalmology. 1999;106:556-563.
19. Burstein NL. Corneal cytotoxicity of topically applied drugs, vehicles and preservatives. Surv Ophthalmol. 1980;25:15-30.
20. Baudouin C. Side effects of antiglaucomatous drugs on the ocular surface. Curr Opin Ophthalmol. 1996;7:80-86.
21. Cantor LB. Bimatoprost. Expert Opin Investig Drugs. 2001;10:721-731.
22. Beebe WE, Starita RJ, Fellman RL, et al. The use of Molteno implant and anterior chamber tube shunt to encircling band for the treatment of glaucoma in keratoplasty patients. Ophthalmology. 1990;97:1414-1422.
23. McDonnell PJ, Robin JB, Schanzlin DJ, et al. Molteno implant for control of glaucoma in eyes after penetrating keratoplasty. Ophthalmology. 1988;95:364-369.
24. Lachkar Y, Hamard P. Nonpenetrating filtering surgery. Curr Opin Ophthalmol. 2002;13:110-115.
25. Hamard P, Lachkar Y. Non penetrating filtering surgery: evolution and results [in French]. J Fr Ophtalmol. 2002;25:527-536.
26. Tragakis MP, Brown SI. The significance of anterior synechiae after corneal transptantation. Am J Ophthalmol. 1972;74:532-533.
27. Arentsen JJ. Corneal transplant allograft reaction: possible predisposing factors. Trans Am Ophthalmol Soc. 1983;81:361-402.
28. Volker-Dieben HJ, D'Amaro J, Kok-van Alphen CC. Hierarchy of prognostic factors for corneal allograft survival. Aust N Z J Ophthalmol. 1987;15:11-18.
29. Hill JC. The relative importance of risk factors used to define high-risk keratoplasty. Ger J Ophthalmol. 1996;5:36-41.
30. The World Almanac and Book of Facts 2001. Manwah, NJ: World Almanac Education Group; 2001.
31. Musch DC, Meyer RF. Risk of endothelial rejection after bilateral penetrating keratoplasty. Ophthalmology. 1989;96:1139-1143.
32. Boisjoly HM, Bernard PM, Dube I, et al. Effect of factors unrelated to tissue matching on corneal transplant endothelial rejection. Am J Ophthalmol. 1989;107:647-654.
33. Barraquer RI, Kargacin M. Prognostic factors in penetrating keratoplasty. Dev Ophthalmol. 1989;18:165-171.
34. Vail A, Gore SM, Bradley BA, et al. Influence of donor and histocompatibility factors on corneal graft outcome. Transplantation. 1994;58:1210-1216.
35. Beck RW, Gal RL, Mannis MJ, et al. Is donor age an important determinant of graft survival? Cornea. 1999;18:503-510.